IN2014CH00269A - - Google Patents

Info

Publication number
IN2014CH00269A
IN2014CH00269A IN269CH2014A IN2014CH00269A IN 2014CH00269 A IN2014CH00269 A IN 2014CH00269A IN 269CH2014 A IN269CH2014 A IN 269CH2014A IN 2014CH00269 A IN2014CH00269 A IN 2014CH00269A
Authority
IN
India
Prior art keywords
retigabine
present application
modification
relates
crystalline
Prior art date
Application number
Other languages
English (en)
Inventor
Srinivasulu Rangineni
Sunitha Vyala
Satish Kumar Vujjini
Ramesh Chakka
Original Assignee
Reddy’S Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy’S Lab Ltd Dr filed Critical Reddy’S Lab Ltd Dr
Priority to IN269CH2014 priority Critical patent/IN2014CH00269A/en
Publication of IN2014CH00269A publication Critical patent/IN2014CH00269A/en

Links

IN269CH2014 2014-01-21 2014-01-21 IN2014CH00269A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN269CH2014 IN2014CH00269A (fr) 2014-01-21 2014-01-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN269CH2014 IN2014CH00269A (fr) 2014-01-21 2014-01-21

Publications (1)

Publication Number Publication Date
IN2014CH00269A true IN2014CH00269A (fr) 2015-08-14

Family

ID=54393600

Family Applications (1)

Application Number Title Priority Date Filing Date
IN269CH2014 IN2014CH00269A (fr) 2014-01-21 2014-01-21

Country Status (1)

Country Link
IN (1) IN2014CH00269A (fr)

Similar Documents

Publication Publication Date Title
IN2014CH00247A (fr)
EA201691582A1 (ru) Новые фармацевтические препараты
MX2019015744A (es) Composiciones farmaceuticas.
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
EP3102554A4 (fr) Conversion de 2, 3-butanediol en butadiène
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX2020009444A (es) Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion.
IN2013MU03641A (fr)
IN2013MU00646A (fr)
EP3212620A4 (fr) Procédé de préparation d'apixaban et d'intermédiaires de ce dernier
MA40313A (fr) Composition pharmaceutique à base d'isotrétinoïne destinée à la voie orale
MX2017015137A (es) Composicion farmaceutica oral de dosis diaria de isotretinoin.
PH12020550871A1 (en) Process for the preparation of opicapone and intermediates thereof
IN2014MU00455A (fr)
EP3229791A4 (fr) Nouveaux polymorphes d'ivacaftor, procédé de préparation de cette molécule et composition pharmaceutique la contenant
IN2014CH00840A (fr)
GEP20196974B (en) A novel crystalline form of a benzimidazole derivative and a preparation method thereof
PL3236764T3 (pl) Sposób wytwarzania kompozycji przyprawowych
MX2016015465A (es) Composicion farmaceutica oral de isotretinoina.
MX2016009667A (es) Forma cristalina alfa del compuesto a monobenzoato y método de preparación de la misma y composición farmacéutica que comprende la misma.
MA40447A (fr) Composition pharmaceutique orale d'isotrétinoïne
GB2559718B (en) Novel crystalline form of tribenuron-methyl, process for preparation and use thereof
IL237572A0 (en) Process and intermediates for the preparation of dastinib
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
IN2013MU02528A (fr)